ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
Chee Young Kim, Sang Hyuk Seo, Min Sung An, Kwang Hee Kim, Ki Beom Bae, Jin Won Hwang, Ji Hyun Kim, Bo Mi Kim, Mi Seon Kang, Min Kyung Oh, Kwan Hee Hong
Ann Coloproctol. 2015;31(3):92-97.   Published online 2015 Jun 30     DOI: https://doi.org/10.3393/ac.2015.31.3.92
Citations to this article as recorded by Crossref logo
Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity
Kai M. Brown, Aiqun Xue, Sohel M. Julovi, Anthony J. Gill, Nick Pavlakis, Jaswinder S. Samra, Ross C. Smith, Thomas J. Hugh
Journal of Surgical Research.2018; 227: 158.     CrossRef
Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
Daniela Rodrigues, Adhemar Longatto-Filho, Sandra F. Martins
BioMed Research International.2016; 2016: 1.     CrossRef
ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
Moo-Jun Baek
Annals of Coloproctology.2015; 31(3): 81.     CrossRef